Latest Breaking News On - Mouna attarha - Page 1 : comparemela.com

White Noise May Harm Brain: Study

The Future of Space Exploration: BrainHQ's Computerized Brain Training for Astronauts – EEJournal

Precision Medicine Approach Reverses Early-Stage Dementia

/PRNewswire/ Amid repeated failures of drug trials for Alzheimer s disease, a small pilot study using a precision medicine approach has reported the first.

Trial First to Show Improvements in Alzheimer's Patients

Trial First to Show Improvements in Alzheimer s Patients News provided by Share this article Share this article BURLINGAME, Calif., May 13, 2021 /PRNewswire/ Pharmaceutical trials for Alzheimer s have failed repeatedly, but a new study, using a fundamentally different approach, has provided the first success: using precision medicine to identify and target the drivers of Alzheimer s or pre-Alzheimer s in each patient, a team of physicians and researchers has posted exciting, positive results in medRxiv, the Yale-backed site for health sciences. (PRNewsfoto/Apollo Health) (PRNewsfoto/Apollo Health) Until now, therapeutic development for Alzheimer s disease has been almost uniformly unsuccessful, with over 400 failed clinical trials. The few successes (e.g., memantine) have not offered sustained improvement. For example, the recent claim of a positive trial for the drug candidate donanemab did not show cognitive improvement, nor even stabilization of dementia, but merely red